CMB 20.0% 36.0¢ cambium bio limited

Ann: Regeneus Market Update, page-8

  1. 173 Posts.
    lightbulb Created with Sketch. 53
    Don't feel sorry for those who left, their choice. Been here since IPO and still believe in long-term upside of RGS due to its rigorous science and smart IP strategy. 10+ years for ROI with a biotech is not surprising. Patience is a virtue. This doesn't mean that I have always been happy with the execution... but after Leo Lee righted the ship, I knew the time would come for RGS to take off. 2022 should be a very interesting year.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.060(20.0%)
Mkt cap ! $4.295M
Open High Low Value Volume
33.0¢ 36.0¢ 33.0¢ $360 1K

Buyers (Bids)

No. Vol. Price($)
1 1498 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 13403 1
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.